Daily PrEP reduces hip, spine BMD in HIV-seronegative patients

[...]changes in bone mineral density (BMD) at 24 weeks for patients taking Truvada (emtricitabine/tenofovir disoproxil fumarate, Gilead Sciences; FTC/TDF) was inversely correlated with intracellular tenofovir diphosphate (TFV-DP), which researchers identified in 53% of study patients.

Saved in:
Bibliographic Details
Published in:Infectious Disease News 2015-09, Vol.28 (9), p.53
Main Author: Craven, Jeff
Format: Article
Language:English
Subjects:
Bone density
HIV
Human immunodeficiency virus
Osteoporosis
Researchers
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 9
container_start_page 53
container_title Infectious Disease News
container_volume 28
creator Craven, Jeff
description [...]changes in bone mineral density (BMD) at 24 weeks for patients taking Truvada (emtricitabine/tenofovir disoproxil fumarate, Gilead Sciences; FTC/TDF) was inversely correlated with intracellular tenofovir diphosphate (TFV-DP), which researchers identified in 53% of study patients.
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_reports_1777424783</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4005574931</sourcerecordid><originalsourceid>FETCH-proquest_reports_17774247833</originalsourceid><addsrcrecordid>eNpjYeA0NDA107U0MjXkYOAqLs4yMDAxNjUx5mSwc0nMzKlUCChyDVAoSk0pTU4tVsjILNBRKC7IzEtVcPJ1UcjMU_DwDNMtTi3Kz0tNTyzJLEtVKABSqXklxTwMrGmJOcWpvFCam0HJzTXE2UO3oCi_sDS1uCS-KLUgv6ikON7Q3NzcxMjE3MLYmChFACs5NcI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777424783</pqid></control><display><type>article</type><title>Daily PrEP reduces hip, spine BMD in HIV-seronegative patients</title><source>EZB Electronic Journals Library</source><creator>Craven, Jeff</creator><creatorcontrib>Craven, Jeff</creatorcontrib><description>[...]changes in bone mineral density (BMD) at 24 weeks for patients taking Truvada (emtricitabine/tenofovir disoproxil fumarate, Gilead Sciences; FTC/TDF) was inversely correlated with intracellular tenofovir diphosphate (TFV-DP), which researchers identified in 53% of study patients.</description><identifier>ISSN: 1056-9251</identifier><language>eng</language><publisher>Thorofare: SLACK INCORPORATED</publisher><subject>Bone density ; HIV ; Human immunodeficiency virus ; Osteoporosis ; Researchers</subject><ispartof>Infectious Disease News, 2015-09, Vol.28 (9), p.53</ispartof><rights>Copyright SLACK INCORPORATED Sep 2015</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>313,786,790,797</link.rule.ids></links><search><creatorcontrib>Craven, Jeff</creatorcontrib><title>Daily PrEP reduces hip, spine BMD in HIV-seronegative patients</title><title>Infectious Disease News</title><description>[...]changes in bone mineral density (BMD) at 24 weeks for patients taking Truvada (emtricitabine/tenofovir disoproxil fumarate, Gilead Sciences; FTC/TDF) was inversely correlated with intracellular tenofovir diphosphate (TFV-DP), which researchers identified in 53% of study patients.</description><subject>Bone density</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Osteoporosis</subject><subject>Researchers</subject><issn>1056-9251</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpjYeA0NDA107U0MjXkYOAqLs4yMDAxNjUx5mSwc0nMzKlUCChyDVAoSk0pTU4tVsjILNBRKC7IzEtVcPJ1UcjMU_DwDNMtTi3Kz0tNTyzJLEtVKABSqXklxTwMrGmJOcWpvFCam0HJzTXE2UO3oCi_sDS1uCS-KLUgv6ikON7Q3NzcxMjE3MLYmChFACs5NcI</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Craven, Jeff</creator><general>SLACK INCORPORATED</general><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20150901</creationdate><title>Daily PrEP reduces hip, spine BMD in HIV-seronegative patients</title><author>Craven, Jeff</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_reports_17774247833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Bone density</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Osteoporosis</topic><topic>Researchers</topic><toplevel>online_resources</toplevel><creatorcontrib>Craven, Jeff</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Infectious Disease News</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Craven, Jeff</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Daily PrEP reduces hip, spine BMD in HIV-seronegative patients</atitle><jtitle>Infectious Disease News</jtitle><date>2015-09-01</date><risdate>2015</risdate><volume>28</volume><issue>9</issue><spage>53</spage><pages>53-</pages><issn>1056-9251</issn><abstract>[...]changes in bone mineral density (BMD) at 24 weeks for patients taking Truvada (emtricitabine/tenofovir disoproxil fumarate, Gilead Sciences; FTC/TDF) was inversely correlated with intracellular tenofovir diphosphate (TFV-DP), which researchers identified in 53% of study patients.</abstract><cop>Thorofare</cop><pub>SLACK INCORPORATED</pub></addata></record>
fulltext fulltext
identifier ISSN: 1056-9251
ispartof Infectious Disease News, 2015-09, Vol.28 (9), p.53
issn 1056-9251
language eng
recordid cdi_proquest_reports_1777424783
source EZB Electronic Journals Library
subjects Bone density
HIV
Human immunodeficiency virus
Osteoporosis
Researchers
title Daily PrEP reduces hip, spine BMD in HIV-seronegative patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T17%3A27%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Daily%20PrEP%20reduces%20hip,%20spine%20BMD%20in%20HIV-seronegative%20patients&rft.jtitle=Infectious%20Disease%20News&rft.au=Craven,%20Jeff&rft.date=2015-09-01&rft.volume=28&rft.issue=9&rft.spage=53&rft.pages=53-&rft.issn=1056-9251&rft_id=info:doi/&rft_dat=%3Cproquest%3E4005574931%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_reports_17774247833%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1777424783&rft_id=info:pmid/&rfr_iscdi=true